KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Receivables (2017 - 2025)

Guardant Health's Receivables history spans 9 years, with the latest figure at $143.0 million for Q4 2025.

  • For Q4 2025, Receivables rose 25.86% year-over-year to $143.0 million; the TTM value through Dec 2025 reached $143.0 million, up 25.86%, while the annual FY2025 figure was $143.0 million, 25.86% up from the prior year.
  • Receivables for Q4 2025 was $143.0 million at Guardant Health, up from $120.7 million in the prior quarter.
  • Across five years, Receivables topped out at $143.0 million in Q4 2025 and bottomed at $65.8 million in Q1 2021.
  • The 5-year median for Receivables is $94.0 million (2023), against an average of $100.5 million.
  • The largest annual shift saw Receivables surged 88.95% in 2021 before it dropped 9.29% in 2023.
  • A 5-year view of Receivables shows it stood at $103.4 million in 2021, then decreased by 0.67% to $102.7 million in 2022, then decreased by 8.74% to $93.7 million in 2023, then grew by 21.32% to $113.7 million in 2024, then increased by 25.86% to $143.0 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Receivables are $143.0 million (Q4 2025), $120.7 million (Q3 2025), and $134.1 million (Q2 2025).